OncoLink - What's New this Week http://www.oncolink.org/whatsnew/ OncoLink - What's New this Week Sat, 29 Aug 2015 21:04:09 GMT OncoLink eNews July/August 2015 http://www.oncolink.orghttp://www.oncolink.org/coping/article.cfm?c=539&id=1177 Receive cutting-edge information from some of the foremost cancer authorities from the University of Pennsylvania, delivered to your email. Tue, 03 Mar 2015 05:00:00 GMT Sonidegib (Odomzo®) http://www.oncolink.org/treatment/article.cfm?c=143&id=7237 Sonidegib is a hedgehog pathway inhibitor used to treat locally advanced basal cell cancers. Fri, 14 Aug 2015 04:00:00 GMT Lenvatinib (Lenvima™) http://www.oncolink.org/treatment/article.cfm?c=143&id=7232 Lenvatininb (Lenvima) is a VEGF tyrosine kinase inhibitor used in the treatment of locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC). Thu, 16 Jul 2015 04:00:00 GMT Dinutuximab (Unituxin ™) http://www.oncolink.org/treatment/article.cfm?c=143&id=7231 Dinutuximab (Unituxin ™) is an intravenous monoclonal antibody for treatment of neuroblastoma. Tue, 14 Jul 2015 04:00:00 GMT Self-Care Series for Oncology Professionals Session IV: Making It Work: Identifying and Embracing Your Self-Care Plan! http://www.oncolink.org/resources/article.cfm?c=1561&id=7211 This continuing education activity is designed to enable the learner to understand the challenges of working in oncology and how they can maintain a healthy work-life balance. Tue, 16 Jun 2015 04:00:00 GMT An Interprofessional Collaborative Approach to Improve Oral Oncolytic Adherence [Continuing Education] http://www.oncolink.org/resources/article.cfm?c=412&id=7178 Welcome to OncoLink's adherence education module for oncology professionals. Mon, 11 May 2015 04:00:00 GMT Molecular Profiling in Advanced Non–Small Cell Lung Cancer: Navigating the New Treatment (CE) http://www.oncolink.org/resources/article.cfm?c=418&id=7175 This activity was developed for a multidisciplinary audience that includes medical, surgical, and radiation oncologists, hematologists, pathologists, hematology/oncology fellows, oncology nurses, and other healthcare professionals involved in the treatment of patients with NSCLC. Mon, 06 Apr 2015 04:00:00 GMT